Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
SRPT News
Articles
Latest stories
Lenmeldy Drug Approval Sparks Pricing Debate; Institute for Clinical and Economic Review Suggests $2.3M - $3.9M Cost-effective for Patients
Authors
4
3 months
Economics
Crime
Business
Biotech Company $SRPT Opens Down 40%, Expected to Close Lower than $10B Valuation
Authors
4
8 months
Economics
Business
CRISPR Genome Editing Continues to Transform Biological Research
Authors
4
9 months
Economics
Business
Previous
Next